Abhijit Kumar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Abhijit Kumar has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Abhinav Sharma
Doctoral School, “Victor Babes” University of Medicine and Pharmacy, 3000041 Timisoara, Romania
1 shared publication Ajay Prasad Hrishi
Department of Neuroanaesthesia and Neurocritical Care, SCTIMST, Thiruvananthapuram, Kerala
1 shared publicationAlphonse Das Aswin
Maulana Azad Medical College (MAMC), New Delhi, India
1 shared publicationAmit Kohli
Maulana Azad Medical College (MAMC), New Delhi, India
1 shared publication- Amit Kohli
Department of Anaesthesiology, Maulana Azad Medical College, New Delhi 110002, India
1 shared publication - Berceanu Vaduva Marcel Mihai
Department XVI-Orthopedics-Traumatology, Urology and Medical Imaging, “Victor Babes” University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania
1 shared publication
Latest Publications
- Open Access
- 20 August 2026
- Published by Wolters Kluwer Health in Indian Journal of Anaesthesia
- Vol. 70 (8) , 951-953
Beyond the numbers: Contextualising the carbon footprint of Desflurane versus Sevoflurane in India
Was not provided for this article.
- 20 August 2026
- Published by Wolters Kluwer Health in Indian Journal of Anaesthesia
- Vol. 70 (8) , 951-953
Open AccessBeyond the numbers: Contextualising the carbon footprint of Desflurane versus Sevoflurane in India
Was not provided for this article.
- Open Access
- 20 April 2026
- Vol. 70 (4) , 526-546
Indian expert consensus on intra-operative consciousness monitoring using processed electroencephalogram-based indices: A Delphi-based approach
In India, depth of anaesthesia monitoring with processed electroencephalogram (pEEG) is not routinely implemented. During volatile-based anaesthesia, end-tidal anaesthetic gas concentrations and age-adjusted minimum alveolar concentration values are widely accepted surrogates of anaesthetic depth. However, these measures do not directly reflect cortical activity, and no equivalent objective surrogate exists during total intravenous anaesthesia (TIVA). pEEG monitoring provides a direct assessment of cerebral activity and may support optimised anaesthetic titration, particularly in TIVA and other high-risk scenarios. The primary objective of this Delphi consensus was to develop expert-based, India-specific recommendations for the use of pEEG-based indices in intra-operative anaesthesia practice. A modified Delphi approach was employed with 15 anaesthesiology experts (13 Indian and 2 international). A Preferred Reporting Items for Systematic Reviews and Meta-analyses-based literature review, covering studies from 2016 to 2025, was conducted to develop 27 draft statements across 10 themes, including indications, target ranges, interpretation, and integration of pEEG with existing monitoring. Through structured iterative rounds involving a steering committee meeting (March 2025), and two rounds of advisory board (May 2025), the statements were revised, eliminated, or accepted based on high (≥80%), moderate (60–80%), or low (<60%) consensus. Of the 27 initial statements, 19 achieved consensus and were included in the final statements. The statements spanned key clinical domains, including the need for depth of anaesthesia monitoring, role of pEEG-based indices, clinical benefits, indications based on anaesthetic techniques (TIVA and inhalational anaesthesia), patient characteristics, surgical context, and practical usage guidance, including target ranges and interpretation. Overall, the consensus supports the use of pEEG monitoring as an adjunct to optimise anaesthetic delivery, reduce drug consumption, and improve recovery profiles, particularly in high-risk and TIVA settings. This Delphi-based consensus provides a clinically relevant framework for integrating pEEG monitoring into anaesthesia practice in India. These recommendations aim to support personalised anaesthetic titration, enhance patient safety, and align peri-operative care with evolving global standards while accounting for local practice variability.
- 20 April 2026
- Vol. 70 (4) , 526-546
Open AccessIndian expert consensus on intra-operative consciousness monitoring using processed electroencephalogram-based indices: A Delphi-based approach
In India, depth of anaesthesia monitoring with processed electroencephalogram (pEEG) is not routinely implemented. During volatile-based anaesthesia, end-tidal anaesthetic gas concentrations and age-adjusted minimum alveolar concentration values are widely accepted surrogates of anaesthetic depth. However, these measures do not directly reflect cortical activity, and no equivalent objective surrogate exists during total intravenous anaesthesia (TIVA). pEEG monitoring provides a direct assessment of cerebral activity and may support optimised anaesthetic titration, particularly in TIVA and other high-risk scenarios. The primary objective of this Delphi consensus was to develop expert-based, India-specific recommendations for the use of pEEG-based indices in intra-operative anaesthesia practice. A modified Delphi approach was employed with 15 anaesthesiology experts (13 Indian and 2 international). A Preferred Reporting Items for Systematic Reviews and Meta-analyses-based literature review, covering studies from 2016 to 2025, was conducted to develop 27 draft statements across 10 themes, including indications, target ranges, interpretation, and integration of pEEG with existing monitoring. Through structured iterative rounds involving a steering committee meeting (March 2025), and two rounds of advisory board (May 2025), the statements were revised, eliminated, or accepted based on high (≥80%), moderate (60–80%), or low (<60%) consensus. Of the 27 initial statements, 19 achieved consensus and were included in the final statements. The statements spanned key clinical domains, including the need for depth of anaesthesia monitoring, role of pEEG-based indices, clinical benefits, indications based on anaesthetic techniques (TIVA and inhalational anaesthesia), patient characteristics, surgical context, and practical usage guidance, including target ranges and interpretation. Overall, the consensus supports the use of pEEG monitoring as an adjunct to optimise anaesthetic delivery, reduce drug consumption, and improve recovery profiles, particularly in high-risk and TIVA settings. This Delphi-based consensus provides a clinically relevant framework for integrating pEEG monitoring into anaesthesia practice in India. These recommendations aim to support personalised anaesthetic titration, enhance patient safety, and align peri-operative care with evolving global standards while accounting for local practice variability.
- Open Access
Impact of Early Diagnosis and Immunosuppressive Therapy on Giant Cell Myocarditis Outcomes: A Review
Background: Giant cell myocarditis (GCM) is a rare condition with an incompletely understood immune pathogenesis, characterized by inflammatory damage to the myocardium and the presence of multinucleated giant cells on histopathological examination. The frequently fulminant and severe course requires rapid intervention for a correct diagnosis and the initiation of immunosuppressive therapy, which is often life-saving. Materials and methods: This article contains information from observational studies and case reports, systematically collected from prestigious publications such as JACC, NEJN, ESC, JCC, Heliyon, and Cureus found in the PubMed and ClinicalTrials.gov databases. Thus, 25 patients diagnosed with giant cell myocarditis between March 2019 and May 2025 were analyzed, with a focus not only on the initial clinical evolution, mortality incidence, and the need for heart transplantation but also on the incidence of major complications such as cardiogenic shock and malignant rhythm and conduction disorders refractory to drug treatment. These parameters were studied according to certain intrinsic factors that cannot be influenced, such as age at onset, gender, and associated pathology of the patient, as well as extrinsic factors that can be influenced, such as the time of diagnosis and the start of immunosuppressive therapy. The results obtained were compared with those in the literature from previous years, considering the limitations of the current study. Results: The selected patients were 13 women (52%) and 12 men (48%), mostly from the US and Japan, aged between 22 and 76 years, with an average age of 44.92 years. An associated autoimmune pathology was found in 40% of patients in this group, and previous cardiovascular pathology in 28%. Only 8% had a history of GCM. The clinical onset of new-onset heart failure, refractory to usual therapy, with progressive dyspnea as the cardinal symptom was found in 12 patients, representing 48% of cases; palpitations as an expression of rhythm or conduction disorders were found in five patients, representing 20%; precordial discomfort to precordial pain accompanied or not by ST-T segment changes was present in four patients, representing 16%; and general signs and symptoms or those of other organs were present in three (12%) cases. The diagnosis was made by histological examination of the biopsy fragment obtained by endomyocardial biopsy or from the myocardial fragment obtained during the implantation of mechanical cardiovascular support devices and, less frequently, on the explanted heart and at autopsy. In terms of progression, of the 25 patients, four (16%) died, four (16%) required heart transplantation, and 16 (64%) had a severe progression with cardiogenic shock, which required mechanical circulatory support in 11 (44%) cases. The outcome was mainly influenced by the early diagnosis and administration of immunosuppressive medication, but also by the age of the patients and associated chronic diseases. Conclusions: Giant cell myocarditis is a serious condition that, in the absence of rapid diagnosis and appropriate immunosuppressive therapy, has a fulminant, often fatal course. Clinical suspicion of giant cell myocarditis remains important in the initial diagnosis. Raising this suspicion, together with modern and improved paraclinical investigations compared to previous years, has led to faster diagnosis and administration of immunosuppressive therapy in this pathology. Histological examination remains the gold standard for final diagnosis, but it should be noted that it may be non-diagnostic. In the face of a strong suspicion of giant cell myocarditis, the best approach is to start immunosuppressive therapy and monitor the patient’s progress. Immunosuppressive treatment remains decisive in influencing the evolution of this condition, both through prompt administration and through the adaptation of therapeutic regimens to the evolution of patients. A more detailed understanding of the immune-mediated pathogenesis of GCM and the identification of clinical risk factors for unfavorable short- and long-term outcomes may enable earlier risk stratification and the development of more targeted, individualized therapeutic strategies.
Open AccessImpact of Early Diagnosis and Immunosuppressive Therapy on Giant Cell Myocarditis Outcomes: A Review
Background: Giant cell myocarditis (GCM) is a rare condition with an incompletely understood immune pathogenesis, characterized by inflammatory damage to the myocardium and the presence of multinucleated giant cells on histopathological examination. The frequently fulminant and severe course requires rapid intervention for a correct diagnosis and the initiation of immunosuppressive therapy, which is often life-saving. Materials and methods: This article contains information from observational studies and case reports, systematically collected from prestigious publications such as JACC, NEJN, ESC, JCC, Heliyon, and Cureus found in the PubMed and ClinicalTrials.gov databases. Thus, 25 patients diagnosed with giant cell myocarditis between March 2019 and May 2025 were analyzed, with a focus not only on the initial clinical evolution, mortality incidence, and the need for heart transplantation but also on the incidence of major complications such as cardiogenic shock and malignant rhythm and conduction disorders refractory to drug treatment. These parameters were studied according to certain intrinsic factors that cannot be influenced, such as age at onset, gender, and associated pathology of the patient, as well as extrinsic factors that can be influenced, such as the time of diagnosis and the start of immunosuppressive therapy. The results obtained were compared with those in the literature from previous years, considering the limitations of the current study. Results: The selected patients were 13 women (52%) and 12 men (48%), mostly from the US and Japan, aged between 22 and 76 years, with an average age of 44.92 years. An associated autoimmune pathology was found in 40% of patients in this group, and previous cardiovascular pathology in 28%. Only 8% had a history of GCM. The clinical onset of new-onset heart failure, refractory to usual therapy, with progressive dyspnea as the cardinal symptom was found in 12 patients, representing 48% of cases; palpitations as an expression of rhythm or conduction disorders were found in five patients, representing 20%; precordial discomfort to precordial pain accompanied or not by ST-T segment changes was present in four patients, representing 16%; and general signs and symptoms or those of other organs were present in three (12%) cases. The diagnosis was made by histological examination of the biopsy fragment obtained by endomyocardial biopsy or from the myocardial fragment obtained during the implantation of mechanical cardiovascular support devices and, less frequently, on the explanted heart and at autopsy. In terms of progression, of the 25 patients, four (16%) died, four (16%) required heart transplantation, and 16 (64%) had a severe progression with cardiogenic shock, which required mechanical circulatory support in 11 (44%) cases. The outcome was mainly influenced by the early diagnosis and administration of immunosuppressive medication, but also by the age of the patients and associated chronic diseases. Conclusions: Giant cell myocarditis is a serious condition that, in the absence of rapid diagnosis and appropriate immunosuppressive therapy, has a fulminant, often fatal course. Clinical suspicion of giant cell myocarditis remains important in the initial diagnosis. Raising this suspicion, together with modern and improved paraclinical investigations compared to previous years, has led to faster diagnosis and administration of immunosuppressive therapy in this pathology. Histological examination remains the gold standard for final diagnosis, but it should be noted that it may be non-diagnostic. In the face of a strong suspicion of giant cell myocarditis, the best approach is to start immunosuppressive therapy and monitor the patient’s progress. Immunosuppressive treatment remains decisive in influencing the evolution of this condition, both through prompt administration and through the adaptation of therapeutic regimens to the evolution of patients. A more detailed understanding of the immune-mediated pathogenesis of GCM and the identification of clinical risk factors for unfavorable short- and long-term outcomes may enable earlier risk stratification and the development of more targeted, individualized therapeutic strategies.
- Open Access
- 15 April 2025
- Published by IP Innovative Publication Pvt Ltd in Indian Journal of Clinical Anaesthesia
- Vol. 12 (2) , 338-342
Spring loaded syringe versus standard loss of resistance syringe for identification of lumbar epidural space: A randomized controlled study
Spring loaded syringe versus standard loss of resistance syringe for identification of lumbar epidural space: A randomized controlled study - IJCA- Print ISSN No: - 2394-4781 Online ISSN No:- 2394-4994 Article DOI No:- 10.18231/j.ijca.2025.053, Indian Journal of Clinical Anaesthesia-Indian J Clin Anaesth
- 15 April 2025
- Published by IP Innovative Publication Pvt Ltd in Indian Journal of Clinical Anaesthesia
- Vol. 12 (2) , 338-342
Open AccessSpring loaded syringe versus standard loss of resistance syringe for identification of lumbar epidural space: A randomized controlled study
Spring loaded syringe versus standard loss of resistance syringe for identification of lumbar epidural space: A randomized controlled study - IJCA- Print ISSN No: - 2394-4781 Online ISSN No:- 2394-4994 Article DOI No:- 10.18231/j.ijca.2025.053, Indian Journal of Clinical Anaesthesia-Indian J Clin Anaesth
- Open Access
- 6 July 2022
- Published by TSNS Interaktiv Plus, LLC
Razvitie meditsinskogo turizma v Indii: poslednee desiatiletie
Medical tourism in India promises a bright spot for multiple reasons both from the side of the arriving patients as well as from the supply side. It has multiple modes of treatment which are availed by the incoming patients from Ayurveda to Buddhist to Herbal medicinal treatments. In terms of pharmaceutical cost and availability as well, India fares better than many countries which are seen especially in generic medicines that India is known for and which have brought India both friendship as well as hostility from countries. The post-COVID world is starkly new in terms of the medical world. It has radically altered how we perceive the medical field and the world around it. India's medical tourism is no exception as it faces challenges in contemporary times. This paper studies the development of medical tourism in India in the previous decade. The study provides an overview of medical tourism in India and the reasons for the country becoming one of the popular choices for patients from abroad.
- 6 July 2022
- Published by TSNS Interaktiv Plus, LLC
Open AccessRazvitie meditsinskogo turizma v Indii: poslednee desiatiletie
Medical tourism in India promises a bright spot for multiple reasons both from the side of the arriving patients as well as from the supply side. It has multiple modes of treatment which are availed by the incoming patients from Ayurveda to Buddhist to Herbal medicinal treatments. In terms of pharmaceutical cost and availability as well, India fares better than many countries which are seen especially in generic medicines that India is known for and which have brought India both friendship as well as hostility from countries. The post-COVID world is starkly new in terms of the medical world. It has radically altered how we perceive the medical field and the world around it. India's medical tourism is no exception as it faces challenges in contemporary times. This paper studies the development of medical tourism in India in the previous decade. The study provides an overview of medical tourism in India and the reasons for the country becoming one of the popular choices for patients from abroad.
- Open Access
- 1 April 2021
- Published by The Korean Society of Anesthesiologists in Korean Journal of Anesthesiology
- Vol. 74 (2) , 103-114
Comeback of ketamine: resurfacing facts and dispelling myths
Initially known as CI-581, ketamine was first synthesized in 1962 as a replacement from phencyclidine. It has since been used as an anesthetic and analgesic. In addition, it has bronchodilating, sedative, and amnestic properties, preserving airway reflexes and sympathetic nervous system tone. Since the discovery of ketamine, it has been a major topic of discussion due to controversies regarding its usage in particular sets of patients. In the past 50 years, despite its potential benefits, it is not commonly used because of concerns of “emergence phenomenon,” its use as a substance of abuse, and its systemic side effects. Since 2012, three World Health Organization reviews on ketamine have addressed its international control.Researchers have been studying this wonder drug for a decade worldwide. Many myths of ketamine regarding emergence phenomenon and its use in traumatic brain injury and open eye injury have been disproved in recent times. It is becoming popular in pre-hospital settings, critical care, emergency medicine, low-dose acute pain services, and adjuvant in regional anesthesia techniques. This review highlights the current consensus on the various applications of ketamine in the literature.
- 1 April 2021
- Published by The Korean Society of Anesthesiologists in Korean Journal of Anesthesiology
- Vol. 74 (2) , 103-114
Open AccessComeback of ketamine: resurfacing facts and dispelling myths
Initially known as CI-581, ketamine was first synthesized in 1962 as a replacement from phencyclidine. It has since been used as an anesthetic and analgesic. In addition, it has bronchodilating, sedative, and amnestic properties, preserving airway reflexes and sympathetic nervous system tone. Since the discovery of ketamine, it has been a major topic of discussion due to controversies regarding its usage in particular sets of patients. In the past 50 years, despite its potential benefits, it is not commonly used because of concerns of “emergence phenomenon,” its use as a substance of abuse, and its systemic side effects. Since 2012, three World Health Organization reviews on ketamine have addressed its international control.Researchers have been studying this wonder drug for a decade worldwide. Many myths of ketamine regarding emergence phenomenon and its use in traumatic brain injury and open eye injury have been disproved in recent times. It is becoming popular in pre-hospital settings, critical care, emergency medicine, low-dose acute pain services, and adjuvant in regional anesthesia techniques. This review highlights the current consensus on the various applications of ketamine in the literature.
- Open Access
- 24 July 2017
- Published by Medip Academy in International Surgery Journal
- Vol. 4 (8) , 2762-2765
Incisional hernia: preliminary observations at a new institute
Background: Ventral hernia develops when an area of the abdominal wall weakens and develops a tear or hole. It may develop as a defect at birth, resulting from incomplete closure of a part of the abdominal wall, or develop where an incision was made during an abdominal surgery, occurring when the incision doesn’t heal properly. Incisional hernia is typically observed within the first 5 years after the surgical incision is made, but may develop long afterwards.1 This study was undertaken to review the history and clinical presentations in patients with incisional hernia, and subsequent treatment. Methods: In the present study, the first 20 cases of incisional hernia admitted to this institute for elective herniorrhaphy were studied. History of the previous surgery was obtained and the findings noted. Treatment carried out was included in the study. Results: Out of 20 cases, 12 were female (60%). Mean age of the patient was 41.9±11.9 years. Lower segment Caesarian section was the commonest preceding surgery (7 out of 12 females; 58.33%). Exploratory laparotomy accounted for 5 out of 8 cases amongst males (62.5%). Commonest site of the hernia was infraumbilical (n=9; 45%). Average size of the defect was 6.2 cm x 5.6 cm. 13 patients underwent surgery. Laparoscopic ventral hernia repair was the most common modality used (10 out of 13; 76.9%). Conclusions: Incisional hernia is more common in females, and gynaecological operations are most common cause and most common site is infraumbilical.
- 24 July 2017
- Published by Medip Academy in International Surgery Journal
- Vol. 4 (8) , 2762-2765
Open AccessIncisional hernia: preliminary observations at a new institute
Background: Ventral hernia develops when an area of the abdominal wall weakens and develops a tear or hole. It may develop as a defect at birth, resulting from incomplete closure of a part of the abdominal wall, or develop where an incision was made during an abdominal surgery, occurring when the incision doesn’t heal properly. Incisional hernia is typically observed within the first 5 years after the surgical incision is made, but may develop long afterwards.1 This study was undertaken to review the history and clinical presentations in patients with incisional hernia, and subsequent treatment. Methods: In the present study, the first 20 cases of incisional hernia admitted to this institute for elective herniorrhaphy were studied. History of the previous surgery was obtained and the findings noted. Treatment carried out was included in the study. Results: Out of 20 cases, 12 were female (60%). Mean age of the patient was 41.9±11.9 years. Lower segment Caesarian section was the commonest preceding surgery (7 out of 12 females; 58.33%). Exploratory laparotomy accounted for 5 out of 8 cases amongst males (62.5%). Commonest site of the hernia was infraumbilical (n=9; 45%). Average size of the defect was 6.2 cm x 5.6 cm. 13 patients underwent surgery. Laparoscopic ventral hernia repair was the most common modality used (10 out of 13; 76.9%). Conclusions: Incisional hernia is more common in females, and gynaecological operations are most common cause and most common site is infraumbilical.